Akebia Therapeutics
AKBA
$1.12
Share price
3.70%
Change (1 day)
2.75%
Change (1 year)
Categories
Market capitalization of Akebia Therapeutics (AKBA)
Market cap: $0.23 Billion
As of June 2024 Akebia Therapeutics has a market cap of $0.23 Billion. This makes Akebia Therapeutics the world's 6820th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Akebia Therapeutics from 2014 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $0.23 B | 0.49% |
| 2023 | $0.23 B | 120.08% |
| 2022 | $0.10 B | -73.16% |
| 2021 | $0.39 B | -2.3% |
| 2020 | $0.40 B | -47.37% |
| 2019 | $0.76 B | 18.97% |
| 2018 | $0.64 B | -8.04% |
| 2017 | $0.70 B | 76.18% |
| 2016 | $0.39 B | 0.71% |
| 2015 | $0.39 B | 67.07% |
| 2014 | $0.23 B |
End of Day market cap according to different sources
On Jun 1st, 2024 the market cap of Akebia Therapeutics was reported to be:
$0.23 Billion
$0.23 Billion
$0.23 Billion
$0.23 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $352.98 B | 150,269.12% | 🇺🇸 USA |
 Novartis NVS | $210.42 B | 89,539.92% | 🇨🇭 Switzerland |
 Amgen AMGN | $164.06 B | 69,791.54% | 🇺🇸 USA |
 Nektar Therapeutics
NKTR | $0.23 B | -0.44% | 🇺🇸 USA |